Cargando…
In Vivo (18)F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by neuroglial tau pathology. A new staging system for PSP pathology postmortem has been described and validated. We used a data-driven approach to test whether postmortem pathologic staging in PSP can be reproduced in...
Autores principales: | Malpetti, Maura, Kaalund, Sanne S., Tsvetanov, Kamen A., Rittman, Timothy, Briggs, Mayen, Allinson, Kieren S.J., Passamonti, Luca, Holland, Negin, Jones, P. Simon, Fryer, Tim D., Hong, Young T., Kouli, Antonina, Bevan-Jones, W. Richard, Mak, Elijah, Savulich, George, Spillantini, Maria Grazia, Aigbirhio, Franklin I., Williams-Gray, Caroline H., O’Brien, John T., Rowe, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612961/ https://www.ncbi.nlm.nih.gov/pubmed/34795013 http://dx.doi.org/10.2967/jnumed.121.262985 |
Ejemplares similares
-
Validation of the new pathology staging system for progressive supranuclear palsy
por: Briggs, Mayen, et al.
Publicado: (2021) -
Structural correlates of survival in Progressive Supranuclear Palsy
por: Street, Duncan, et al.
Publicado: (2023) -
Neuroinflammation predicts disease progression in progressive supranuclear palsy
por: Malpetti, Maura, et al.
Publicado: (2021) -
Molecular pathology and synaptic loss in primary tauopathies: an (18)F-AV-1451 and (11)C-UCB-J PET study
por: Holland, Negin, et al.
Publicado: (2021) -
[(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2018)